Serving Boulder County Since 1949

How I Treat Lichen Sclerosus: A Dermatologist’s Approach to Long-Term Care

How I Treat Lichen Sclerosus: A Dermatologist’s Approach to Long-Term Care

Lichen sclerosus is a chronic inflammatory skin condition that most commonly affects the vulva and the skin around the anus. It can cause itching, burning, soreness, painful intercourse, skin tearing, and progressive changes in the vulvar anatomy if left untreated.

As a dermatologist, one of the most important things I want patients to understand is that lichen sclerosus is treatable, and long-term control is absolutely achievable. However, successful treatment requires more than simply relieving symptoms. My approach focuses on controlling inflammation, preventing scarring, addressing associated symptoms, and monitoring the skin over time.

Here is how I approach treatment and what I want every patient with lichen sclerosus to know.


1. Clobetasol: The Cornerstone of Treatment

My first-line treatment for vulvar lichen sclerosus is typically clobetasol propionate 0.05% ointment, an ultrapotent topical corticosteroid.

I know that recommending a very strong steroid for use on genital skin can sound intimidating. Many patients have heard that steroids thin the skin or should never be used long term. While topical steroids can cause side effects when used inappropriately, lichen sclerosus is an important exception to the general fear surrounding steroid use.

The goal is not to avoid steroids. The goal is to use the right steroid, in the right amount, on the right areas, with appropriate follow-up.

Clobetasol suppresses the inflammation responsible for the itching, irritation, skin fragility, and progressive scarring associated with lichen sclerosus. Treating this inflammation can improve symptoms and help prevent further architectural changes to the vulva.

How I use clobetasol

For many newly diagnosed patients, I start with a structured treatment course over approximately three months. A common regimen is to start applying twice daily for 1-3 months, then taper to once daily for a few months, followed by three times a week.

The exact schedule may vary depending on disease severity, treatment response, and individual circumstances. I also make sure patients understand exactly where to apply the medication, because proper application is essential for successful treatment.

After the initial treatment phase, some patients can reduce their use substantially, while others need ongoing maintenance treatment to keep inflammation under control. Lichen sclerosus is a chronic condition, so maintenance therapy is often an important part of long-term care.

Is long-term clobetasol use safe on vulvar skin?

This is one of the most common concerns I hear, and it deserves a clear answer.

When used appropriately under medical supervision, clobetasol is safe for long-term management of vulvar lichen sclerosus.

The vulva, including the labia minora and clitoris, is actually very resistant to thinning from topical steroids. The outer labia (labia majora) and thigh folds, however, are much thinner and more prone to side effects. So I spend a lot of time making sure that my patients know exactly where to apply their medication. Studies and clinical guidelines also support long-term, individualized treatment with potent topical steroids for this condition.

One of the biggest challenges I encounter is steroid phobia—a fear of topical steroids that leads patients to use their medication too infrequently, stop treatment too soon, or avoid maintenance therapy altogether.

Under-treatment can allow inflammation to persist even when symptoms temporarily improve. Over time, ongoing disease can contribute to scarring, fusion of vulvar structures, changes in anatomy, and continued discomfort.

I would much rather help a patient use clobetasol correctly and confidently than have them suffer from inadequately treated disease because they are afraid of their medication.


2. Topical Estradiol: An Important Adjunct for Some Patients

Clobetasol treats the inflammation caused by lichen sclerosus, but it does not address every possible cause of vulvar discomfort.

For some patients, particularly those who are perimenopausal or postmenopausal, low-estrogen-related changes can occur alongside lichen sclerosus. These changes may contribute to dryness, burning, irritation, tissue fragility, and painful intercourse.

In these situations, I may recommend topical estradiol cream as an adjunct to clobetasol.

Topical estradiol helps improve the health and moisture of estrogen-responsive vulvovaginal tissues. It can be particularly helpful when genitourinary syndrome of menopause is contributing to symptoms.

Estradiol does not replace clobetasol as the primary treatment for lichen sclerosus. The two medications address different problems and can complement one another when both inflammatory skin disease and low-estrogen tissue changes are present.

Not everyone with lichen sclerosus needs topical estrogen. I individualize this recommendation based on symptoms, examination findings, menopausal status, and other relevant medical considerations.


3. Monitoring for Skin Cancer: Why Follow-Up Matters

Lichen sclerosus is associated with an increased risk of developing squamous cell carcinoma in the affected genital skin. Although the absolute risk is low—generally estimated at approximately 3–5% for vulvar lichen sclerosus—it is important enough that I take surveillance seriously.

I want to emphasize two things:

  • First, most patients with lichen sclerosus will never develop vulvar cancer. A diagnosis of lichen sclerosus is not a reason to live in fear.
  • Second, leaving the condition untreated or persistently active is a concern. Chronic inflammation and inadequately controlled disease are associated with malignant change, which is why effective treatment and regular monitoring matter. Treatment may reduce this risk, although it does not eliminate it.

During follow-up visits, I assess how well the inflammation is controlled, look for changes in vulvar anatomy, and check for any areas that warrant further evaluation.

I also educate patients about changes they should bring to my attention, including:

  • A new lump, growth, or thickened area.
  • A persistent ulcer, sore, or area that does not heal.
  • A new rough, crusted, or otherwise changing lesion.
  • A localized area of persistent pain, bleeding, or irritation that does not improve with appropriate treatment.

A suspicious or persistent lesion may require a biopsy. Not every change is cancer, but do not assume every new symptom is simply another lichen sclerosus flare.

I generally recommend ongoing clinical follow-up, with the interval individualized according to disease activity, treatment needs, prior findings, and individual risk factors. Patients should also know how to perform gentle self-awareness checks and when to seek an earlier appointment.


4. Pelvic Floor Physical Therapy: Treating More Than the Skin

Another important part of my approach is considering whether pelvic floor physical therapy could benefit the patient.

Lichen sclerosus can make intercourse painful because of active inflammation, skin fissures, scarring, or changes in the vulvar opening. When pain persists, the pelvic floor muscles can become tense or overactive in response. This can create a cycle in which pain leads to muscle guarding, which then contributes to additional pain and difficulty with intercourse.

Even after the skin inflammation is well controlled, some patients continue to experience discomfort because of pelvic floor muscle dysfunction or pain-related muscle tension.

For these patients, I often recommend evaluation by a pelvic floor physical therapist with experience in vulvar pain and pelvic floor disorders.

Depending on the individual’s needs, therapy may include muscle relaxation, breathing techniques, manual therapy, gradual desensitization, and strategies to improve comfort with daily activities or intercourse.

Pelvic floor physical therapy does not treat the underlying lichen sclerosus itself. Still, it can be a valuable part of a comprehensive treatment plan when pelvic floor dysfunction contributes to symptoms.


5. Simple Vulvar Skin Care Makes a Difference

In addition to prescription treatment, I encourage patients to minimize irritation and protect the skin barrier.

My general recommendations include:

  • Avoid fragranced soaps, wipes, sprays, and other potentially irritating products on the vulva.
  • Use lukewarm water and a gentle, fragrance-free cleanser or an appropriate soap substitute only. Avoid applying any soap directly to the inner labia.
  • Apply a bland barrier ointment, such as plain petrolatum, when helpful to reduce friction and irritation.
  • Avoid activities or products that repeatedly trigger skin irritation, and use a generous amount of water-based lubricant when needed for sexual activity.
  • Follow the prescribed treatment plan rather than stopping medication as soon as itching improves.

These measures are supportive, not a substitute for anti-inflammatory treatment.


The Bottom Line

Lichen sclerosus is a chronic condition, but it does not have to dictate your comfort, sexual health, or quality of life.

My treatment approach centers on four priorities:

  1. Control inflammation with clobetasol ointment, using an appropriate initial course and individualized maintenance therapy.
  2. Address contributing factors with topical estradiol when low-estrogen tissue changes are also present.
  3. Monitor the skin over time to identify persistent inflammation, progressive scarring, or suspicious lesions early.
  4. Treat associated pain and muscle dysfunction with pelvic floor physical therapy when appropriate.

Let’s Talk

If you have been diagnosed with lichen sclerosus and have been hesitant to use your prescribed steroid, please bring those concerns to your dermatologist. Understanding how to use the medication safely is far more helpful than avoiding effective treatment out of fear.

With the right treatment plan and consistent follow-up, most patients can achieve meaningful symptom relief and maintain good long-term disease control.

My colleague, Dr. Lindsay Boyers, and I trained at the University of Colorado, where a dual board-certified dermatologist and OB-GYN mentored us and led a dedicated vulvar dermatology clinic. That experience provided specialized training in diagnosing and treating vulvar dermatoses (skin conditions affecting the vulva) and shaped our shared focus in this area of care.

Meet Jenna Peart, MD, and make an appointment.

The information in this article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your health care provider regarding any medical condition or before making changes to your treatment plan.
BACK